Recruiting PHASE4 INTERVENTIONAL 1-arm
NCT07159282
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
Sponsor: Applied Biologics, LLC
Conditions
DFU Diabetic Foot Diabetic Foot Ulcer Foot Ulcer Foot Ulcer Due to Type 1 Diabetes Mellitus Foot Ulcer Due to Type 2 Diabetes Mellitus Ulcer Foot
Interventions
XWRAP
Updated 2 times since 2025 Last updated: Feb 9, 2026 Started: Aug 26, 2025 Primary completion: Aug 31, 2027 Completion: Aug 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on DFU and Diabetic Foot, this trial is actively recruiting participants. The trial is conducted by Applied Biologics, LLC and has accumulated 2 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
2 versions recorded-
Feb 2026 — Present [monthly]
Recruiting PHASE4
-
Oct 2025 — Feb 2026 [monthly]
Recruiting PHASE4
First recorded
Aug 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Applied Biologics, LLC
- SerenaGroup, Inc.
Data source: Applied Biologics, LLC
For direct contact, visit the study record on ClinicalTrials.gov .